ArticleTrials2018

Apatinib for patients with advanced or recurrent cervical cancer: study protocol for an open-label randomized controlled trial.

Jian-Guo Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.